Annekathrin Haberland

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 5

Top Topics

Mesenchymal Stem Cells

Systemic Lupus Erythematosus

Binding Protein

Top Venues

Clinical drug investigation

Cardiovascular drugs and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Annekathrin Haberland, Oxana Krylova, Heike Nikolenko, Peter Göttel, Andre Dallmann, Johannes Müller, Hardy Weisshoff
Aptamer BC 007's Affinity to Specific and Less-Specific Anti-SARS-CoV-2 Neutralizing Antibodies. Viruses 13 (5) (2021)
Niels-Peter Becker, Annekathrin Haberland, Katrin Wenzel, Peter Göttel, Gerd Wallukat, Hanna Davideit, Sarah Schulze-Rothe, Anne-Sophie Hönicke, Ingolf Schimke, Sabine Bartel, Matthias Grossmann, Angela Sinn, Laura Iavarone, Jan H Boergermann, Kiley Prilliman, Georg Golor, Johannes Müller, Susanne Becker
A Three-Part, Randomised Study to Investigate the Safety, Tolerability, Pharmacokinetics and Mode of Action of BC 007, Neutraliser of Pathogenic Autoantibodies Against G-Protein Coupled Receptors in Healthy, Young and Elderly Subjects. Clinical drug investigation 40 (5) (2020)
Annekathrin Haberland, Johannes Müller, Katrin Wenzel
Activation of T Lymphocytes as a Novel Mechanism in Beta1-Adrenergic Receptor Autoantibody-Induced Cardiac Remodeling-Additional Information About TLR9 Involvement. Cardiovascular drugs and therapy 33 (6) (2020)
Hanna Davideit, Susanne Becker, Johannes Müller, Niels-Peter Becker, Peter Göttel, Ayşe Abay, Angela Sinn, Matthias Grossmann, Markus Mallek, Annekathrin Haberland, Hardy Weisshoff
In-Vivo Degradation of DNA-Based Therapeutic BC 007 in Humans. European journal of drug metabolism and pharmacokinetics 44 (4) (2019)
Katrin Wenzel, Sarah Schulze-Rothe, Johannes Müller, Gerd Wallukat, Annekathrin Haberland
Difference between beta1-adrenoceptor autoantibodies of human and animal origin-Limitations detecting beta1-adrenoceptor autoantibodies using peptide based ELISA technology. PloS one 13 (2) (2018)